A new standard in research. A world of possibility.Discover the Peptivia standard

Collection / VIP

PEPTIVIAVIP10 mgVIAL · RESEARCH USE ONLY× 3
General research · vial

VIP

VIP is a 28-amino-acid neuropeptide involved in vasoactive signalling. Research explores vascular physiology and peptide-mediated communication.

$281.99 CAD

Simulation only · No real order or payment.

BrandPEPTIVIA
Format / strengthvial · 10 mg
Pack quantity3

28-amino-acid neuropeptide

Also known as: Vasoactive Intestinal Peptide

Human physiology
Research & handling

Not for human or veterinary use. Storage, handling, identity and purity require verified batch documentation. No dosing or treatment advice is provided.

RESEARCH FOCUS

At a glance

Vascular physiology

Supplied acute human physiology findings concern haemodynamic responses.

Neuropeptide signalling

Vasoactive Intestinal Peptide is a specific signalling identity.

Experimental context

Acute physiology findings are different from long-term treatment outcomes.

Explore the study context and sources below. For laboratory research only.

EXPLORE THE EVIDENCE

Studies & context

Studied in small human physiology experiments for changes in coronary blood-vessel resistance.

Human physiology
Human physiology

An acute 1989 experiment in 11 men reported lower coronary and systemic vascular resistance during VIP infusion.

Study limitations

A small physiology experiment, not a long-term treatment or safety trial.

Smitherman et al., 1989 ↗
Human physiology

Experiments in four additional men supported a direct coronary vasodilator effect.

Study limitations

Measured circulation changes do not establish general cardiovascular benefits or PEPTIVIA material equivalence.

Smitherman et al., 1989 ↗

Published research is separate from PEPTIVIA identity, content, purity, sterility and batch documentation. No source-supplier report verifies PEPTIVIA material.